Du Y - Search Results

1

Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial.

Zhu Y, Du Y, Liu H, Ma T, Shen Y, Pan Y. Zhu Y, et al. Among authors: du y. Thorac Cancer. 2016 Nov;7(6):663-669. doi: 10.1111/1759-7714.12384. Epub 2016 Aug 24. Thorac Cancer. 2016. PMID: 27755796 Free PMC article. Clinical Trial.

2

Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.

Wu H, Chen Z, Sun G, Gu K, Pan Y, Hao J, Du Y, Ning J. Wu H, et al. Among authors: du y. J Exp Clin Cancer Res. 2009 Mar 7;28(1):33. doi: 10.1186/1756-9966-28-33. J Exp Clin Cancer Res. 2009. PMID: 19267934 Free PMC article.

3

Lack of association between interleukin-8-251 T>A polymorphism and colorectal cancer risk: a meta-analysis based on 3,019 cases and 3,984 controls.

Hu LX, Du YY, Zhang Y, Pan YY. Hu LX, et al. Among authors: du yy. Asian Pac J Cancer Prev. 2012;13(10):5075-9. doi: 10.7314/apjcp.2012.13.10.5075. Asian Pac J Cancer Prev. 2012. PMID: 23244113 Free article.

4

Synergistic effects of exemestane and aspirin on MCF-7 human breast cancer cells.

Hu LX, Du YY, Zhang Y, Pan YY. Hu LX, et al. Among authors: du yy. Asian Pac J Cancer Prev. 2012;13(11):5903-8. doi: 10.7314/apjcp.2012.13.11.5903. Asian Pac J Cancer Prev. 2012. PMID: 23317278 Free article.

5

The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.

Lei Y, Li HX, Jin WS, Peng WR, Zhang CJ, Bu LJ, Du YY, Ma T, Sun GP. Lei Y, et al. Among authors: du yy. Int J Radiat Biol. 2013 Dec;89(12):1079-86. doi: 10.3109/09553002.2013.825058. Epub 2013 Oct 25. Int J Radiat Biol. 2013. PMID: 23875954

6

Lack of association between vitamin D receptor gene BsmI polymorphism and breast cancer risk: an updated meta-analysis involving 23,020 subjects.

Du Y, Hu L, Kong F, Pan Y. Du Y, et al. Tumour Biol. 2014 Mar;35(3):2087-93. doi: 10.1007/s13277-013-1277-y. Epub 2013 Nov 20. Tumour Biol. 2014. PMID: 24248540 Free PMC article.

7

Lack of association between the FAS/FASL polymorphisms and cervical cancer risk: A meta-analysis.

DU Y, Hu L, Pan Y. DU Y, et al. Biomed Rep. 2013 Mar;1(2):269-274. doi: 10.3892/br.2013.56. Epub 2013 Jan 17. Biomed Rep. 2013. PMID: 24648934 Free PMC article.

8

Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells.

Shen YY, Yuan Y, Du YY, Pan YY. Shen YY, et al. Among authors: du yy. Mol Med Rep. 2015 Jul;12(1):623-30. doi: 10.3892/mmr.2015.3411. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738368

9

Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.

Shen Y, Du Y, Zhang Y, Pan Y. Shen Y, et al. Among authors: du y. Mol Med Rep. 2015 Jul;12(1):456-62. doi: 10.3892/mmr.2015.3406. Epub 2015 Mar 3. Mol Med Rep. 2015. PMID: 25738757

10

Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.

Kong F, Wu J, Hu L, Du Y, Pan Y. Kong F, et al. Among authors: du y. Int J Clin Exp Med. 2015 Apr 15;8(4):6412-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,796 results

Search Page

Filters